,Chapter ,01: ,The ,Nursing ,Process ,and ,Drug ,Therapy .................................................................................. 4
Chapter ,02: ,Pharmacologic ,Principles .......................................................................................................... 8
Chapter ,03: ,Lifespan ,Considerations .......................................................................................................... 14
Chapter ,04: ,Cultural, ,Legal, ,and ,Ethical ,Considerations ........................................................................... 20
Chapter ,05: ,Medication ,Errors: ,Preventing ,and ,Responding .................................................................... 26
Chapter ,06: ,Patient ,Education ,and ,Drug ,Therapy .................................................................................... 29
Chapter ,07: ,Over-the-Counter ,Drugs ,and ,Herbal ,and ,Dietary ,Supplements ........................................... 34
Chapter ,08: ,Gene ,Therapy ,and ,Pharmacogenomics ................................................................................. 38
Chapter ,09: ,Photo ,Atlas ,of ,Drug ,Administration....................................................................................... 41
Chapter ,10: ,Analgesic ,Drugs....................................................................................................................... 50
Chapter ,11: ,General ,and ,Local ,Anesthetics............................................................................................... 57
Chapter ,12: ,Central ,Nervous ,System ,Depressants ,and ,Muscle ,Relaxants ............................................... 61
Chapter ,13: ,Central ,Nervous ,System ,Stimulants ,and ,Related ,Drugs ....................................................... 66
Chapter ,14: ,Antiepileptic ,Drugs ................................................................................................................. 70
Chapter ,15: ,Antiparkinson ,D r u g s . . . . . . . . . . . . . . . . . .N. .U. . .R. . S. .I. N
. . .G. . .T. .B. . ..C. . .O. . M........................................... 76
Chapter ,16: ,Psychotherapeutic ,Drugs ........................................................................................................ 81
Chapter ,17: ,Substance ,Use ,Disorder ......................................................................................................... 88
Chapter ,18: ,Adrenergic ,Drugs .................................................................................................................... 93
Chapter ,19: ,Adrenergic-Blocking ,Drugs ..................................................................................................... 98
Chapter ,20: ,Cholinergic ,Drugs.................................................................................................................. 103
Chapter ,21: ,Cholinergic-Blocking ,Drugs ................................................................................................... 108
Chapter ,22: ,Antihypertensive ,Drugs ........................................................................................................ 113
Chapter ,23: ,Antianginal ,Drugs ................................................................................................................. 119
Chapter ,24: ,Heart ,Failure ,Drugs .............................................................................................................. 125
Chapter ,25: ,Antidysrhythmic ,Drugs ......................................................................................................... 131
Chapter ,26: ,Coagulation ,Modifier ,Drugs ................................................................................................. 137
Chapter ,27: ,Antilipemic ,Drugs ................................................................................................................. 143
Chapter ,28: ,Diuretic ,Drugs ....................................................................................................................... 148
Chapter ,29: ,Fluids ,and ,Electrolytes.......................................................................................................... 154
Chapter ,30: ,Pituitary ,Drugs ...................................................................................................................... 160
Chapter ,31: ,Thyroid ,and ,Antithyroid ,Drugs ............................................................................................ 163
,Chapter ,32: ,Antidiabetic ,Drugs ................................................................................................................ 168
Chapter ,33: ,Adrenal ,Drugs ....................................................................................................................... 177
Chapter ,34: ,Women’s ,Health ,Drugs ........................................................................................................ 181
Chapter ,35: ,Men’s ,Health ,Drugs .............................................................................................................. 188
Chapter ,36: ,Antihistamines, ,Decongestants, ,Antitussives, ,and ,Expectorants ........................................ 193
Chapter ,37: ,Respiratory ,Drugs ................................................................................................................. 198
Chapter ,38: ,Antibiotics ,Part ,1 .................................................................................................................. 204
Chapter ,39: ,Antibiotics ,Part ,2 .................................................................................................................. 211
Chapter ,40: ,Antiviral ,Drugs ...................................................................................................................... 216
Chapter ,41: ,Antitubercular ,Drugs ............................................................................................................ 221
Chapter ,42: ,Antifungal ,Drugs ................................................................................................................... 226
Chapter ,43: ,Antimalarial, ,Antiprotozoal, ,and ,Anthelmintic ,Drugs.......................................................... 231
Chapter ,44: ,Anti-inflammatory ,and ,Antigout ,Drugs ............................................................................... 236
Chapter ,45: ,Antineoplastic ,Drugs ,Part ,1: ,Cancer ,Overview ,and ,Cell ,Cycle–Specific ,Drugs .................. 242
Chapter ,46: ,Antineoplastic ,Drugs ,Part ,2: ,Cell ,Cycle–Nonspecific ,Drugs ,and ,Miscellaneous ,Drugs ...... 248
NURSINGTB.COM
Chapter ,47: ,Biologic ,Response–Modifying ,and ,Antirheumatic ,Drugs ..................................................... 253
Chapter ,48: ,Immunosuppressant ,Drugs................................................................................................... 258
Chapter ,49: ,Immunizing ,Drugs ................................................................................................................. 263
Chapter ,50: ,Acid-Controlling ,Drugs .......................................................................................................... 268
Chapter ,51: ,Bowel ,Disorder ,Drugs .......................................................................................................... 274
Chapter ,52: ,Antiemetic ,and ,Antinausea ,Drugs ....................................................................................... 281
Chapter ,53: ,Vitamins ,and ,Minerals ......................................................................................................... 286
Chapter ,54: ,Anemia ,Drugs ....................................................................................................................... 292
Chapter ,55: ,Nutritional ,Supplements ...................................................................................................... 299
Chapter ,56: ,Dermatologic ,Drugs .............................................................................................................. 304
Chapter ,57: ,Ophthalmic ,Drugs ................................................................................................................. 310
Chapter ,58: ,Otic ,Drugs ............................................................................................................................. 315
, Chapter ,01: ,The ,Nursing ,Process ,and ,Drug ,Therapy
MULTIPLE ,CHOICE
1. The ,nurse ,is ,writing ,a ,nursing ,diagnosis ,for ,a ,plan ,of ,care ,for ,a ,patient ,who ,has ,been
,newly ,diagnosed ,with ,type ,2 ,diabetes. ,Which ,statement ,reflects ,the ,correct ,format ,for ,a
,nursing ,diagnosis?
a. Anxiety
b. Anxiety ,related ,to ,new ,drug ,therapy
c. Anxiety ,related ,to ,anxious ,feelings ,about ,drug ,therapy, ,as ,evidenced ,by
,statements
such ,as ,―I‘m ,upset ,about ,having ,to ,test ,my ,blood ,sugars.‖
d. Anxiety ,related ,to ,new ,drug ,therapy, ,as ,evidenced ,by ,statements ,such ,as ,―I‘m
upset ,about ,having ,to ,test ,my ,blood ,sugars.‖
ANS: , D
Formulation ,of ,nursing ,diagnoses ,is ,usually ,a ,three-step ,process. ,―Anxiety‖ ,is ,missing ,the
―related ,to‖ ,and ,―as ,evidenced ,by‖ ,portions ,of ,defining ,characteristics. ,―Anxiety ,related ,to
,new ,drug ,therapy‖ ,is ,missing ,the ,―as ,evidenced ,by‖ ,portion ,of ,defining ,characteristics. ,The
,statement ,beginning ,―Anxiety ,related ,to ,anxious ,feelings‖ ,is ,incorrect ,because ,the ,―related ,to‖
,section ,is
simply ,a ,restatement ,of ,the ,problem ,―anxiety,‖ ,not ,a ,separate ,factor ,related ,to ,the ,response.
DIF: COGNITIVE ,LEVEL: ,Understanding ,(Comprehension)
,TOP: , NURSING ,PROCESS: ,Nursing
,DiagNnUosRiSs INGTB.COM
MSC: , NCLEX: ,Safe ,and ,Effective ,Care ,Environment: ,Management ,of ,Care
2. The ,patient ,is ,to ,receive ,oral ,guaifenesin ,(Mucinex) ,twice ,a ,day. ,Today, ,the ,nurse ,was ,busy
,and ,gave ,the ,medication ,2 ,hours ,after ,the ,scheduled ,dose ,was ,due. ,What ,type ,of ,problem
,does ,this ,represent?
a. ―Right ,time‖
b. ―Right ,dose‖
c. ―Right ,route‖
d. ―Right ,medication‖
ANS: , A
―Right ,time‖ ,is ,correct ,because ,the ,medication ,was ,given ,more ,than ,30 ,minutes ,after ,the
scheduled ,dose ,was ,due. ,―Dose‖ ,is ,incorrect ,because ,the ,dose ,is ,not ,related ,to ,the ,time ,the
medication ,administration ,is ,scheduled. ,―Route‖ ,is ,incorrect ,because ,the ,route ,is ,not ,affected.
,―Medication‖ ,is ,incorrect ,because ,the ,medication ,ordered ,will ,not ,change.
DIF: COGNITIVE ,LEVEL: ,Applying ,(Application)
,TOP: , NURSING ,PROCESS: ,Implementation
MSC: , NCLEX: ,Safe ,and ,Effective ,Care ,Environment: ,Safety ,and ,Infection ,Control
3. The ,nurse ,has ,been ,monitoring ,the ,patient‘s ,progress ,on ,a ,new ,drug ,regimen ,since ,the ,first
,dose ,and ,documenting ,the ,patient‘s ,therapeutic ,response ,to ,the ,medication. ,Which ,phase ,of
,the ,nursing ,process ,do ,these ,actions ,illustrate?
a. Nursing ,diagnosis
NURSINGTB.COM
Chapter ,02: ,Pharmacologic ,Principles .......................................................................................................... 8
Chapter ,03: ,Lifespan ,Considerations .......................................................................................................... 14
Chapter ,04: ,Cultural, ,Legal, ,and ,Ethical ,Considerations ........................................................................... 20
Chapter ,05: ,Medication ,Errors: ,Preventing ,and ,Responding .................................................................... 26
Chapter ,06: ,Patient ,Education ,and ,Drug ,Therapy .................................................................................... 29
Chapter ,07: ,Over-the-Counter ,Drugs ,and ,Herbal ,and ,Dietary ,Supplements ........................................... 34
Chapter ,08: ,Gene ,Therapy ,and ,Pharmacogenomics ................................................................................. 38
Chapter ,09: ,Photo ,Atlas ,of ,Drug ,Administration....................................................................................... 41
Chapter ,10: ,Analgesic ,Drugs....................................................................................................................... 50
Chapter ,11: ,General ,and ,Local ,Anesthetics............................................................................................... 57
Chapter ,12: ,Central ,Nervous ,System ,Depressants ,and ,Muscle ,Relaxants ............................................... 61
Chapter ,13: ,Central ,Nervous ,System ,Stimulants ,and ,Related ,Drugs ....................................................... 66
Chapter ,14: ,Antiepileptic ,Drugs ................................................................................................................. 70
Chapter ,15: ,Antiparkinson ,D r u g s . . . . . . . . . . . . . . . . . .N. .U. . .R. . S. .I. N
. . .G. . .T. .B. . ..C. . .O. . M........................................... 76
Chapter ,16: ,Psychotherapeutic ,Drugs ........................................................................................................ 81
Chapter ,17: ,Substance ,Use ,Disorder ......................................................................................................... 88
Chapter ,18: ,Adrenergic ,Drugs .................................................................................................................... 93
Chapter ,19: ,Adrenergic-Blocking ,Drugs ..................................................................................................... 98
Chapter ,20: ,Cholinergic ,Drugs.................................................................................................................. 103
Chapter ,21: ,Cholinergic-Blocking ,Drugs ................................................................................................... 108
Chapter ,22: ,Antihypertensive ,Drugs ........................................................................................................ 113
Chapter ,23: ,Antianginal ,Drugs ................................................................................................................. 119
Chapter ,24: ,Heart ,Failure ,Drugs .............................................................................................................. 125
Chapter ,25: ,Antidysrhythmic ,Drugs ......................................................................................................... 131
Chapter ,26: ,Coagulation ,Modifier ,Drugs ................................................................................................. 137
Chapter ,27: ,Antilipemic ,Drugs ................................................................................................................. 143
Chapter ,28: ,Diuretic ,Drugs ....................................................................................................................... 148
Chapter ,29: ,Fluids ,and ,Electrolytes.......................................................................................................... 154
Chapter ,30: ,Pituitary ,Drugs ...................................................................................................................... 160
Chapter ,31: ,Thyroid ,and ,Antithyroid ,Drugs ............................................................................................ 163
,Chapter ,32: ,Antidiabetic ,Drugs ................................................................................................................ 168
Chapter ,33: ,Adrenal ,Drugs ....................................................................................................................... 177
Chapter ,34: ,Women’s ,Health ,Drugs ........................................................................................................ 181
Chapter ,35: ,Men’s ,Health ,Drugs .............................................................................................................. 188
Chapter ,36: ,Antihistamines, ,Decongestants, ,Antitussives, ,and ,Expectorants ........................................ 193
Chapter ,37: ,Respiratory ,Drugs ................................................................................................................. 198
Chapter ,38: ,Antibiotics ,Part ,1 .................................................................................................................. 204
Chapter ,39: ,Antibiotics ,Part ,2 .................................................................................................................. 211
Chapter ,40: ,Antiviral ,Drugs ...................................................................................................................... 216
Chapter ,41: ,Antitubercular ,Drugs ............................................................................................................ 221
Chapter ,42: ,Antifungal ,Drugs ................................................................................................................... 226
Chapter ,43: ,Antimalarial, ,Antiprotozoal, ,and ,Anthelmintic ,Drugs.......................................................... 231
Chapter ,44: ,Anti-inflammatory ,and ,Antigout ,Drugs ............................................................................... 236
Chapter ,45: ,Antineoplastic ,Drugs ,Part ,1: ,Cancer ,Overview ,and ,Cell ,Cycle–Specific ,Drugs .................. 242
Chapter ,46: ,Antineoplastic ,Drugs ,Part ,2: ,Cell ,Cycle–Nonspecific ,Drugs ,and ,Miscellaneous ,Drugs ...... 248
NURSINGTB.COM
Chapter ,47: ,Biologic ,Response–Modifying ,and ,Antirheumatic ,Drugs ..................................................... 253
Chapter ,48: ,Immunosuppressant ,Drugs................................................................................................... 258
Chapter ,49: ,Immunizing ,Drugs ................................................................................................................. 263
Chapter ,50: ,Acid-Controlling ,Drugs .......................................................................................................... 268
Chapter ,51: ,Bowel ,Disorder ,Drugs .......................................................................................................... 274
Chapter ,52: ,Antiemetic ,and ,Antinausea ,Drugs ....................................................................................... 281
Chapter ,53: ,Vitamins ,and ,Minerals ......................................................................................................... 286
Chapter ,54: ,Anemia ,Drugs ....................................................................................................................... 292
Chapter ,55: ,Nutritional ,Supplements ...................................................................................................... 299
Chapter ,56: ,Dermatologic ,Drugs .............................................................................................................. 304
Chapter ,57: ,Ophthalmic ,Drugs ................................................................................................................. 310
Chapter ,58: ,Otic ,Drugs ............................................................................................................................. 315
, Chapter ,01: ,The ,Nursing ,Process ,and ,Drug ,Therapy
MULTIPLE ,CHOICE
1. The ,nurse ,is ,writing ,a ,nursing ,diagnosis ,for ,a ,plan ,of ,care ,for ,a ,patient ,who ,has ,been
,newly ,diagnosed ,with ,type ,2 ,diabetes. ,Which ,statement ,reflects ,the ,correct ,format ,for ,a
,nursing ,diagnosis?
a. Anxiety
b. Anxiety ,related ,to ,new ,drug ,therapy
c. Anxiety ,related ,to ,anxious ,feelings ,about ,drug ,therapy, ,as ,evidenced ,by
,statements
such ,as ,―I‘m ,upset ,about ,having ,to ,test ,my ,blood ,sugars.‖
d. Anxiety ,related ,to ,new ,drug ,therapy, ,as ,evidenced ,by ,statements ,such ,as ,―I‘m
upset ,about ,having ,to ,test ,my ,blood ,sugars.‖
ANS: , D
Formulation ,of ,nursing ,diagnoses ,is ,usually ,a ,three-step ,process. ,―Anxiety‖ ,is ,missing ,the
―related ,to‖ ,and ,―as ,evidenced ,by‖ ,portions ,of ,defining ,characteristics. ,―Anxiety ,related ,to
,new ,drug ,therapy‖ ,is ,missing ,the ,―as ,evidenced ,by‖ ,portion ,of ,defining ,characteristics. ,The
,statement ,beginning ,―Anxiety ,related ,to ,anxious ,feelings‖ ,is ,incorrect ,because ,the ,―related ,to‖
,section ,is
simply ,a ,restatement ,of ,the ,problem ,―anxiety,‖ ,not ,a ,separate ,factor ,related ,to ,the ,response.
DIF: COGNITIVE ,LEVEL: ,Understanding ,(Comprehension)
,TOP: , NURSING ,PROCESS: ,Nursing
,DiagNnUosRiSs INGTB.COM
MSC: , NCLEX: ,Safe ,and ,Effective ,Care ,Environment: ,Management ,of ,Care
2. The ,patient ,is ,to ,receive ,oral ,guaifenesin ,(Mucinex) ,twice ,a ,day. ,Today, ,the ,nurse ,was ,busy
,and ,gave ,the ,medication ,2 ,hours ,after ,the ,scheduled ,dose ,was ,due. ,What ,type ,of ,problem
,does ,this ,represent?
a. ―Right ,time‖
b. ―Right ,dose‖
c. ―Right ,route‖
d. ―Right ,medication‖
ANS: , A
―Right ,time‖ ,is ,correct ,because ,the ,medication ,was ,given ,more ,than ,30 ,minutes ,after ,the
scheduled ,dose ,was ,due. ,―Dose‖ ,is ,incorrect ,because ,the ,dose ,is ,not ,related ,to ,the ,time ,the
medication ,administration ,is ,scheduled. ,―Route‖ ,is ,incorrect ,because ,the ,route ,is ,not ,affected.
,―Medication‖ ,is ,incorrect ,because ,the ,medication ,ordered ,will ,not ,change.
DIF: COGNITIVE ,LEVEL: ,Applying ,(Application)
,TOP: , NURSING ,PROCESS: ,Implementation
MSC: , NCLEX: ,Safe ,and ,Effective ,Care ,Environment: ,Safety ,and ,Infection ,Control
3. The ,nurse ,has ,been ,monitoring ,the ,patient‘s ,progress ,on ,a ,new ,drug ,regimen ,since ,the ,first
,dose ,and ,documenting ,the ,patient‘s ,therapeutic ,response ,to ,the ,medication. ,Which ,phase ,of
,the ,nursing ,process ,do ,these ,actions ,illustrate?
a. Nursing ,diagnosis
NURSINGTB.COM
